Levi & Korsinsky, LLP: CEO and CFO Named as Control Person Defendants in Inovio Pharmaceuticals Securities Action
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ:AMEX Investor Relations:
ir.inovio.com/investors/default.aspx
Company Research
Source: GlobeNewswire
NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Two senior executives of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) are named as individual defendants in a securities class action: Jacqueline E. Shea, President and Chief Executive Officer; and Peter Kies, Chief Financial Officer. The pleading asserts these individuals had the power and authority to control the contents of the Company's SEC filings, press releases, and market communications. To be considered for lead plaintiff, investors must file by April 7, 2026. Request information for institutional investors or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com | (212) 363-7500. The Named Individual Defendants The complaint charges that Jacqueline E. Shea served as Inovio's President and Chief Executive Officer at all relevant times. As averred, Peter Kies served as the Company's Chief Financial Officer. The pleading asserts both individuals possessed the power to control the Company's public disclosures and were provided wi
Show less
Read more
Impact Snapshot
Event Time:
INO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INO alerts
High impacting Inovio Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
INO
News
- Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitPR Newswire
- Bronstein, Gewirtz & Grossman LLC Urges Inovio Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire
- Portnoy Law Firm Announces Class Action on Behalf of Inovio Pharmaceuticals, Inc. InvestorsGlobeNewswire
- INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law FirmGlobeNewswire
- ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INOGlobeNewswire
INO
Earnings
- 3/12/26 - Beat
INO
Analyst Actions
- 12/30/25 - HC Wainwright
INO
Sec Filings
- 3/12/26 - Form 8-K
- 3/12/26 - Form 10-K
- 3/5/26 - Form 4
- INO's page on the SEC website